Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Otto C Boerman

Showing results (41-50 of 319) with videos related to

Pageof 32
Sort By:
EJNMMI Research|February 2, 2013
Effects of attenuation map accuracy on attenuation-corrected micro-SPECT imagesChao Wu, Hugo A Gratama van Andel, Peter Laverman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2006
Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosisManuel J Koppe, Thijs Hendriks, Otto C Boerman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2003
Pretargeted radioimmunotherapy of cancer: progress step by stepOtto C Boerman, Frank G van Schaijk, Wim J G Oyen, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 17, 2007
Radionuclide therapy of cancer with radiolabeled antibodiesOtto C Boerman, Manuel J Koppe, E J Postema, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 28, 2007
Development and application of peptide-based radiopharmaceuticalsIngrid Dijkgraaf, Otto C Boerman, Wim J G Oyen, et al.
EJNMMI Research|December 13, 2019
Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer modelsFortuné M K Elekonawo, Desirée L Bos, David M Goldenberg, et al.
Scientific Reports|May 13, 2017
Preclinical evaluation of PAC1 targeting with radiolabeled MaxadilanLieke Joosten, Maarten Brom, Martin K H Schäfer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2003
Underestimation of absorbed dose to kidneyErnst J Postema, Wilhelmina C A M Buijs, Otto C Boerman, et al.
European Urology|April 3, 2010
Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapyAlexander B Stillebroer, Peter F A Mulders, Otto C Boerman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 8, 2014
Monitoring the biological effect of BMP-2 release on bone healing by PET/CTManuela Ventura, Otto C Boerman, Gerben M Franssen, et al.
Pageof 32

Showing results (41-50 of 319) with videos related to

Sort By:
Pageof 32
EJNMMI Research|February 2, 2013
Effects of attenuation map accuracy on attenuation-corrected micro-SPECT imagesChao Wu, Hugo A Gratama van Andel, Peter Laverman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2006
Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosisManuel J Koppe, Thijs Hendriks, Otto C Boerman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2003
Pretargeted radioimmunotherapy of cancer: progress step by stepOtto C Boerman, Frank G van Schaijk, Wim J G Oyen, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 17, 2007
Radionuclide therapy of cancer with radiolabeled antibodiesOtto C Boerman, Manuel J Koppe, E J Postema, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 28, 2007
Development and application of peptide-based radiopharmaceuticalsIngrid Dijkgraaf, Otto C Boerman, Wim J G Oyen, et al.
EJNMMI Research|December 13, 2019
Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer modelsFortuné M K Elekonawo, Desirée L Bos, David M Goldenberg, et al.
Scientific Reports|May 13, 2017
Preclinical evaluation of PAC1 targeting with radiolabeled MaxadilanLieke Joosten, Maarten Brom, Martin K H Schäfer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2003
Underestimation of absorbed dose to kidneyErnst J Postema, Wilhelmina C A M Buijs, Otto C Boerman, et al.
European Urology|April 3, 2010
Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapyAlexander B Stillebroer, Peter F A Mulders, Otto C Boerman, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 8, 2014
Monitoring the biological effect of BMP-2 release on bone healing by PET/CTManuela Ventura, Otto C Boerman, Gerben M Franssen, et al.
Pageof 32